Dr. Franklyn Nonso Iheagwam is a biochemist and molecular biology researcher with a prolific background in diabetes research, coagulation, multi‑omics biomarker discovery, and phytopharmacology. He Postdoctoral Fellowship position at the University of Colorado in the Department of Biochemistry & Molecular Genetics in Denver, USA. His work is centered on understanding altered coagulation profiles in trauma settings, especially as influenced by diabetes mellitus, and identifying plant-derived bioactive compounds with anti‑diabetic or anti‑thrombotic properties. His research has examined the anti‑diabetic and antioxidative effects of extracts like Terminalia catappa leaf extract, demonstrated to reverse insulin resistance, modulate clotting parameters, and mitigate oxidative stress in diabetic rat models. He has authored and co‑authored over 70 peer‑reviewed papers in leading journals.